IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune reset: could a single infusion tame lupus and other autoimmune diseases?
Disease control Recruiting nowThis early-stage study tests a new cell therapy called FT819 in people with moderate-to-severe autoimmune diseases like lupus, vasculitis, myositis, and scleroderma. The goal is to see if it is safe and can reduce disease activity by targeting faulty B-cells. About 244 participan…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:01 UTC
-
Cord stem cells aim to tame rare muscle disease
Disease control Recruiting nowThis study tests whether stem cells from umbilical cord lining can safely improve symptoms of dermatomyositis and polymyositis, rare diseases that cause muscle weakness and inflammation. Forty adults will receive three IV doses of the stem cells or a placebo, then switch groups. …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE2, PHASE3 • Sponsor: Restem, LLC. • Aim: Disease control
Last updated May 14, 2026 12:01 UTC